Replies to post #16130 on Plandai Biotechnology Inc (PLPL)

[DR. EVIL]

Perfect! Exactly what I’m looking for. At least I found somebody who understands what do diligence is. I appreciate your help my friend.

[Truenorth2016]

We are going to get a massive 2021 style run on this stock if and when that merger is closed and the new CEO Jessie Chang start dropping news. That Puriblood /PLPL last PR sounds like it is done and they are just waiting on the ink to dry. Cant believe something like this is setting up at the 000's levels. Again, as I said before here and will keep saying to everyone, it will be nice to have TX*TM involved here, but even if they are not this can produce a strong run on its own.

[stervc]

marylandstockguy, with those PLPL thoughts...

Thanks for sharing. I read your post last week regarding PLPL:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169183550

It was on point as indicated within the PLPL PR below:

SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
https://www.accesswire.com/705983/SEC-Cancels-Regulatory-Penalty-and-Interest-Concerning-Legacy-Civil-Enforcement-Action

Important to note too was that within the latest PLPL filings on page 10 and 11, there were no legal proceedings existing:
https://www.otcmarkets.com/otcapi/company/financial-report/333940/content

In case anyone was wanting further confirmation of PuriBlood Medical being the company coming into PLPL, one could scroll to the bottom page of their website below and see that it matches the address that is in the initial PLPL PR below:

https://puriblood.com/en/
2F, No.11, Gongye E. 9th Rd., Baoshan Township, Hsinchu County 300096, Taiwan (R.O.C.)

https://www.otcmarkets.com/stock/PLPL/news/Plandai-Biotechnology-In-Non-Binding-Letter-of-Intent-to-Acquire-Rights-to-Puribloods-Leukocyte-Reduction-Blood-Filtrati?id=358235
Puriblood is a U.S. registered trademark of Puriblood Medical Co., Ltd. Corporation Taiwan 2f., No. 11, Gongye E. 9th Rd. Hsinchu County 30075 Taiwan R.O.C.

v/r
Sterling